Lekshmi Santhosh is a Respiratory physician affiliated with University of California, San Francisco. OpenAlex indexes 130 publications with 1,146 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.7%Corticosteroid53.7%Trelegy Ellipta48%Symbicort28%Fluticasone Propionate15%Flovent Hfa10%Part D<11 patientsbeta2-Adrenergic Agonist17.9%Albuterol Sulfate Hfa66%Ventolin Hfa34%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
10%Proton pump inhibitor5.2%Omeprazole100%Part D<11 patientsH2 blocker4.8%Famotidine100%Part D<11 patientsCancer & immunology
5.2%Pyridone5.2%Pirfenidone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Broadening the scale and impact of a comprehensive Long COVID clinic to serve diverse patient groups with multidisciplinary care and research access
University of California, San Francisco
FY2026$1,000,000U18HS029951 - Broadening the scale and impact of a comprehensive Long COVID clinic to serve diverse patient groups with multidisciplinary care and research access
University of California, San Francisco
FY2025$1,000,000U18HS029951 - Broadening the scale and impact of a comprehensive Long COVID clinic to serve diverse patient groups with multidisciplinary care and research access
University of California, San Francisco
FY2024$1,000,000U18HS029951
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Kristine Yaffe, MD
University of California, San Francisco
Elyse Foster, MD
University of California, San Francisco
William Seeley, MD
University of California, San Francisco
Talmadge King, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”